SEC Filing Details

Document Details

Form
Filing Date
Apr 10, 2020
Document Date
Apr 8, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aravive Biologics
Issuer
Aravive, Inc.
Filer
ESHELMAN FREDRIC N